نتائج البحث - "Morabito A."

1

دورية أكاديمية

Single-cell landscape in mammary epithelium reveals bipotent-like cells associated with breast cancer risk and outcome

المؤلفون: Chen, Weiyan, Morabito, Samuel J, Kessenbrock, Kai, Enver, Tariq, Meyer, Kerstin B, Teschendorff, Andrew E

المصدر: Communications Biology. 2(1)

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9rr367rrTest

View record in eScholarship

2

دورية أكاديمية

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

المساهمون: Cortellini, A., Giusti, R., Filetti, M., Citarella, F., Adamo, V., Santini, D., Buti, S., Nigro, O., Cantini, L., Di Maio, M., Aerts, J. G. J. V., Bria, E., Bertolini, F., Ferrara, M. G., Ghidini, M., Grossi, F., Guida, A., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Antonuzzo, L., Gelibter, A., Marchetti, P., Chiari, R., Macerelli, M., Rastelli, F., Della Gravara, L., Gori, S., Tuzi, A., De Tursi, M., Di Marino, P., Mansueto, G., Pecci, F., Zoratto, F., Ricciardi, S., Migliorino, M. R., Passiglia, F., Metro, G., Spinelli, G. P., Banna, G. L., Friedlaender, A., Addeo, A., Ficorella, C., Porzio, G., Tiseo, M., Russano, M., Russo, A., Pinato, D. J.

مصطلحات موضوعية: ddr gene, family history of cancer, immune checkpoint inhibitor, immunotherapy, nsclc, pembrolizumab, carcinoma, non-small-cell lung, dna damage, female, human, lung neoplasm, male, treatment outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35062993; info:eu-repo/semantics/altIdentifier/wos/WOS:000745488900001; volume:15; issue:1; firstpage:1; lastpage:6; numberofpages:6; journal:JOURNAL OF HEMATOLOGY & ONCOLOGY; http://hdl.handle.net/11573/1620815Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123438477

الإتاحة: https://doi.org/10.1186/s13045-022-01226-2Test
http://hdl.handle.net/11573/1620815Test

View record in BASE

3

دورية أكاديمية

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

المؤلفون: Gridelli C., Morabito A., Cavanna L., Luciani A., Maione P., Bonanno L., Filipazzi V., Leo S., Cinieri S., Ciardiello F., Burgio M. A., Bilancia D., Cortinovis D., Rosetti F., Bianco R., Gebbia V., Artioli F., Bordonaro R., Fregoni V., Mencoboni M., Nelli F., Riccardi F., Di Isernia G., Costanzo R., Rocco G., Daniele G., Signoriello S., Piccirillo M. C., Gallo C., Perrone F.

المساهمون: Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M., Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C., Perrone, F.

مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Non-Small-Cell Lung, Cisplatin, Deoxycytidine, Female, Human, Kaplan-Meier Estimate, Lung Neoplasm, Male, Pemetrexed, Quality of Life, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000445669200004; volume:36; issue:25; firstpage:2585; lastpage:2592; numberofpages:8; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11588/823700Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85052571799

الإتاحة: https://doi.org/10.1200/JCO.2017.76.8390Test
http://hdl.handle.net/11588/823700Test

View record in BASE

4

دورية أكاديمية

Effect of pituitary-dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas.

المؤلفون: Rapastella, Sofia, Morabito, Simona, Sharman, Mellora, Benoit, Jérôme, Schiavo, Luca, Morris, Joanna, Dobson, Jane Margaret, Scudder, Christopher John

مصطلحات موضوعية: Cushing, PDH, adenohypophysis, adrenal gland, canine, endocrinology, enocrinology, hyperadrenocorticism, pituitary gland, Humans, Dogs, Animals, Pituitary Neoplasms, Retrospective Studies, Cushing Syndrome, Pituitary ACTH Hypersecretion, Adrenocortical Hyperfunction, Treatment Outcome, Dog Diseases

وصف الملف: text/xml; application/pdf

العلاقة: https://www.repository.cam.ac.uk/handle/1810/350170Test

الإتاحة: https://www.repository.cam.ac.uk/handle/1810/350170Test

View record in BASE

5

IntravaScular Lithotripsy for the Management of UndILatable Coronary StEnt: The SMILE Registry

المساهمون: Ielasi, A., Moscarella, E., Testa, L., Gioffre, G., Morabito, G., Cortese, B., Colangelo, S., Tomai, F., Arioli, F., Maioli, M., Leoncini, M., Tumminello, G., Benedetto, S., Lucchina, P. G., Pennesi, M., Ugo, F., Vigano, E., Bollati, M., Missiroli, B., Gaspardone, A., Calabro, P., Bedogni, F., Tespili, M.

المصدر: Cardiovascular Revascularization Medicine. 21:1555-1559

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e87e991893a662edcfc98dd3c2c768Test
https://doi.org/10.1016/j.carrev.2020.05.020Test

6

دورية أكاديمية

Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial.

مصطلحات موضوعية: Afatinib, Aged, Carcinoma, Squamous Cell, Disease-Free Survival, Erlotinib Hydrochloride, Female, Genes, erbB, Humans, Lung Neoplasms, Male, Middle Aged, Mutation, Protein Kinase Inhibitors, Treatment Outcome

العلاقة: http://hdl.handle.net/10668/12594Test; PMC6143014; https://jamanetwork.com/journals/jamaoncology/articlepdf/2684635/jamaoncology_goss_2018_oi_180020.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143014/pdfTest

الإتاحة: https://doi.org/10.1001/jamaoncol.2018.0775Test
http://hdl.handle.net/10668/12594Test
https://jamanetwork.com/journals/jamaoncology/articlepdf/2684635/jamaoncology_goss_2018_oi_180020.pdfTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143014/pdfTest

View record in BASE

7

Performance of a multi-compounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease

المساهمون: Brandimarte, Giovanni, Frajese, Giovanni V, Bargiggia, Stefano, Castellani, Danilo, Cocco, Andrea, Colucci, Raffaele, Evangelista, Enrica, Gravina, Antonietta G, Napoletano, Domenico, Nardi, Elisabetta, Maisto, Tammaro, Morabito, Antonino, Pianese, Giuseppe, Romano, Antonio, Sacco, Rodolfo, Sediar I, Luca, Sinnona, Nicola, Tifi, Lorenza, Davino, Alessandro, Elisei, Walter, Tursi, Antonio

مصطلحات موضوعية: Diverticular Diseases, Male, Endocrinology, Diabetes and Metabolism, Gastroenterology, Middle Aged, Treatment Outcome, Dietary Supplements, Internal Medicine, Humans, Female, Leukocyte L1 Antigen Complex, Diverticulitis, Aged, Retrospective Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8856572d56afa2c4dec07544891304ebTest
http://hdl.handle.net/11591/469940Test

8

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

المساهمون: Crino L., Bidoli P., Delmonte A., Grossi F., De Marinis F., Ardizzoni A., Vitiello F., Lo Russo G., Parra H.S., Cortesi E., Cappuzzo F., Calabro L., Tiseo M., Turci D., Gamucci T., Antonelli P., Morabito A., Chella A., Giannarelli D., Galetta D., Crinò, L, Bidoli, P, Delmonte, A, Grossi, F, De Marinis, F, Ardizzoni, A, Vitiello, F, Lo Russo, G, Parra, H, Cortesi, E, Cappuzzo, F, Calabrò, L, Tiseo, M, Turci, D, Gamucci, T, Antonelli, P, Morabito, A, Chella, A, Giannarelli, D, Galetta, D

المصدر: The Oncologist. 24:e1165-e1171

مصطلحات موضوعية: Compassionate Use Trials, Male, 0301 basic medicine, Oncology, real-world, Cancer Research, Lung Neoplasms, Squamous non‐small cell lung cancer, Cohort Studies, Efficacy, Antineoplastic Agents, Immunological, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 80 and over, Medicine, squamous non-small cell lung cancer, Non-Small-Cell Lung, Aged, 80 and over, education.field_of_study, Lung Cancer, Expanded access program, Immunotherapy, Nivolumab, Real‐world, Treatment beyond disease progression, Adult, Aged, Drug Administration Schedule, Female, Humans, Italy, Middle Aged, Safety, Treatment Outcome, Immunological, expanded access program, Docetaxel, 030220 oncology & carcinogenesis, Cohort, treatment beyond disease progression, medicine.drug, medicine.medical_specialty, Population, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, Adverse effect, education, business.industry, Carcinoma, Clinical trial, 030104 developmental biology, Expanded access, immunotherapy, business